1009298-09-2COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1COKVLFRAWTRWDEDF-IRXDYDNUSA-NAZD-8055 is a pyridopyrimidine that is pyrido[2,3-d]pyrimidine which is substituted at positions 2 and 4 by (3S)-3-methylmorpholin-4-yl groups and at position 5 by a 3-(hydroxymethyl)-4-methoxyphenyl group. It is an mTOR complex 1/2 (mTORC1/2) dual inhibitor [mTOR = mammalian target of rapamycin]. It has a role as an antineoplastic agent, a mTOR inhibitor and an apoptosis inducer. It is a member of benzyl alcohols, a member of morpholines, a pyridopyrimidine and a tertiary amino compound.
Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Warning
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
VerwendenA novel ATP-competitive inhibitor of mTOR with an IC50 of 0.8 nM.
Wird geladen…
Wird geladen…
Wird geladen…
1009298-09-2DTXSID001020704CHEMBL1801204CHEBI:91329